ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
0,00%
Bitcoin
63.658,66
-0,37%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. SeaStar Medical Holding Corporation (ICU)

  7. SeaStar Medical Holding Corporation (ICU) News

ICU SeaStar Medical Holding Corporation

0,4551
-0,0382 (-7,74%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
SeaStar Medical Holding Corporation ICU NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,0382 -7,74% 0,4551 06:00:10
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,49 0,4421 0,5093 0,4486 0,4933
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202414:30GLOBESeaStar Medical Announces $3.6 Million NIH Grant Award to..
17.4.202422:00GLOBESeaStar Medical Reports 2023 Financial Results and Provides..
11.4.202414:30GLOBESeaStar Medical to Present at the Noble Capital Markets’..
27.3.202413:30GLOBESeaStar Medical to Restate Financials, Sets Business Update..
12.3.202413:30GLOBESeaStar Medical Provides Updates on Enrollment of Adult..
11.3.202421:05GLOBESeaStar Medical-Sponsored Symposium Featuring Experts..
27.2.202414:30GLOBEManuscript Discussing the Benefit of SeaStar Medical’s..
22.2.202413:58GLOBENuwellis’ Distribution Partner, SeaStar Medical, Receives..
22.2.202413:53GLOBEFDA Grants Humanitarian Device Exemption Approval to SeaStar..
01.2.202414:30GLOBESeaStar Medical Granted Canadian Patent with Broad Claims..
26.1.202414:05GLOBESeaStar Medical Announces Pricing of $9.0 Million Registered..
11.1.202422:05GLOBESeaStar Medical Appoints David A. Green as Chief Financial..
09.1.202414:30GLOBESeaStar Medical Issued U.S. Patent with Broad Claims..
28.12.202314:30GLOBESeaStar Medical Updates Subject Enrollment in its Pivotal..
13.12.202314:30GLOBESeaStar Medical Forms Scientific Advisory Board of..
14.11.202322:04GLOBESeaStar Medical Reports Third Quarter 2023 Financial Results..
31.10.202313:00GLOBENuwellis’ Strategic Partner, SeaStar Medical, Receives FDA..
30.10.202313:00GLOBEFDA Issues Approvable Letter for SeaStar Medical’s Selective..
18.10.202314:30GLOBEFDA Grants SeaStar Medical’s Selective Cytopheretic Device..
05.10.202314:30GLOBESeaStar Medical to Present at the Dawson James Small Cap..
03.10.202322:05GLOBESeaStar Medical Provides Regulatory Update Regarding..
29.9.202314:30GLOBEFDA Grants Breakthrough Device Designation to SeaStar..
21.9.202315:35GLOBEDawson James Securities Announces October Date for 8th..
30.8.202322:35EDGAR2Form 8-K - Current report
29.8.202314:00GLOBECase Series of Three Critically Ill Children with Acute..
24.8.202323:15EDGAR2Form 8-K - Current report
22.8.202314:00GLOBESeaStar Medical to Hold Business Update Conference Call..
17.8.202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.8.202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.8.202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.8.202322:45EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15.8.202322:43EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15.8.202322:41EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15.8.202322:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15.8.202312:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15.8.202312:11EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15.8.202312:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15.8.202312:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15.8.202312:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14.8.202323:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202322:36EDGAR2Form PRE 14A - Other preliminary proxy statements
14.8.202322:35GLOBESeaStar Medical Reports Second Quarter 2023 Financial..
14.8.202322:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14.8.202322:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14.8.202322:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10.8.202322:00EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
02.8.202322:19EDGAR2Form 8-K - Current report
01.8.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
20.7.202323:11EDGAR2Form S-1 - General form for registration of securities under..
05.7.202323:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

Kürzlich von Ihnen besucht

NASDAQ
ICU
SeaStar Medical
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten